期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

嗜酸性粒细胞增多及细胞遗传学异常对急性非淋巴细胞白血病M4预后的影响:GIMEMA试验 被引量：2

M4 Acute Myeloid Leukemia: The Role of Eosinophilia and Cytogenetics in Treatment Response and Survival the GIMEMA Experience
下载PDF
导出
摘要 1 文献来源 M4 acute myeloid leukemia：The role of eosinophilia and cytogenetics in treatment response and survival The GIMEMA experience [J]. Haematologica, 2008, 93（7） ： 1025 -1032.
作者 王健民 邵宇 佘妙容
机构地区 第二军医大学附属长海医院血液科 广东省人民医院肿瘤中心血液科
出处 《循证医学》 CSCD 2009年第5期281-283,286,共4页 The Journal of Evidence-Based Medicine
关键词 急性非淋巴细胞白血病M4 嗜酸性粒细胞增 多 细胞遗传学 16号染色体的倒置或突变 预后 M4 acute mycloid leukemia eosinophilia cytogenetics Inv（16） prognosis
分类号 R733.71 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1Byrd JC, Mrozek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461) [J]. Blood, 2002,100( 13 ) : 4325-4336.
  • 2Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes [J]. Blood, 2009, 114(5) :937-951.
  • 3Dtihner K, Dohner H. Molecular characterization of acute myeloid leukemia [J]. Haematologica, 2008,93(7) : 976-982.
  • 4Paschka P, Marcucci G, Ruppert AS, et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A Cancer and Leukemia Group B Study [J]. J Clin Oncol, 2006,24(24):3904-3911.
  • 5Mrozek K, Bloomfield CD. Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia [J]. Hematology Am Soc Hematol Educ Program, 2006:169-177.
  • 6Marcucci G, Mrozek K, Ruppert AS, et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t (8;21) differ from those of patients with inv (16): A Cancer and Leukemia Group B study [J]. J Clin Oncol, 2005,23 (24) : 5705-5717.

同被引文献26

  • 1Mitelman F.An international system for human cgtogenetic nomenclature[M]. Basel : Karger S, 1995.
  • 2Hoelzer D, Goekbuget N.Treatment of acute lymphoblastic leukemia in adults [ J ]. Blood Reviews, 2007,21 (Suppl. 1 ) : S61 -S66.
  • 3O' Brien S, Thall PF, Siciliano MJ. Cytogenetics of chronic myelogenous leukemia[J].Baillieres Clin Haematol, 1997,10(2) : 259-276.
  • 4Sole F, Espinet B, Sanz GF, et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes[J].Br J Haematol, 2000, 108(2) : 346-356.
  • 5Byrd JC,Mrozek K,Dodge RK,et al. Pretreatment cytogeneticabnormalities are predictive of induction success,cumulativeincidence of relapse,and overall survival in adult patients with denovo acute myeloid leukemia :results from Cancer and LeukemiaGroup B (CALGB 8461). Blood,2002;100(13) :4325 -4336.
  • 6Hamerschlak N. Leukemia :genetics and prognostic factors. JPediatr,2008; 84 (4 Suppl) :S52 -S57.
  • 7Mrozek K,Bloomfield CD. Clinical significance of the mostcommon chromosome translocations in adult acute myeloidleukemia. J Nati Cancer Inst Monogr,2008;2008(39) :52 -57.
  • 8张之南,沈悌.血液病诊断与疗效标准.第3版.北京:科学出版社,2008:99 -163.
  • 9Cheson BD,Bennett JM,Kopecky KJ,et al. Revised recom-mendations of the international working group for diagnosis,standardization of response criteria,treatment outcomes,andreporting standards for therapeutic trials in acute myeloid leukemia.J Clin Oncol,2003;21(24) :4642 - 4649.
  • 10Liu P,Tarle SA,Hajra A,et al. Fusion between transcriptionfactor CBF beta/PEBP2 beta and a myosin heavy chain in acutemyeloid leukemia. Science,1993 ;261 (5124) :1041 - 1044.

引证文献2

二级引证文献7

循证医学
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部